| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |